Letters to the Editor

Morbihan disease in an Asian patient: diagnostic and therapeutic challenges

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 28 April 2026
27
Views
8
Downloads

Authors

Dear Editor,

Morbihan disease (MD) is a rare condition affecting mainly middle-aged Caucasian adults, characterized by persistent swelling of the upper face. First described in 1956, it was named by Gorin et al. in 1991 after a French patient from the Morbihan region. The etiology remains unclear and is likely multifactorial, involving lymphatic drainage impairment and chronic vascular inflammation, supporting its association with rosacea. Histological findings parallel those of rosacea, characterized by perivascular and inflammatory infiltrates, dermal edema, and sebaceous gland hyperplasia. Diagnosis relies on clinical features and ruling out other conditions that look similar. [...]

Downloads

Download data is not yet available.

Citations

1. Veraldi S, Persico MC, Francia C. Morbihan syndrome. Indian Dermatol Online J 2013;4:122-4.
2. Mayur O, Martinez R, McNichol MC, McGee JS. Clinical and histological features and treatment outcomes of patients with Morbihan disease: a systematic review. Arch Dermatol Res 2023;315:2427-9.
3. van der Linden MM, Arents BW, van Zuuren EJ. Diagnosis and treatment of Morbihan’s disease: a practical approach based on review of the literature. J Clin Aesthet Dermatol 2023;16:22-30.
4. Ramirez-Bellver JL, Pérez-González YC, Chen KR et al. Clinicopathological and Immunohistochemical Study of 14 Cases of Morbihan Disease: An Insight Into Its Pathogenesis. Am J Dermatopathol 2019;41:701-10.
5. Park J, Kim MB, Choi HY, Yang SW. Novel prognostic factors and combination therapy outcomes in Morbihan disease: insights from an Asian population. BMC Ophthalmol 2024;24:496.
6. Yilmaz O, Bose R, Colantonio S. Low-dose isotretinoin for the treatment of Morbihan's disease in a 69-year-old Asian male: A case report. SAGE Open Med Case Rep 2025;13:2050313X251320214.
7. Dhawan SR, Saini AG, Singhi PD. Management Strategies of Melkersson-Rosenthal Syndrome: A Review. Int J Gen Med 2020;13:61-5.
8. Oh Y, Stoll JR, Moskowitz A, et al. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management. J Am Acad Dermatol 2021;85:1093-106.
9. Ciccarese G, Trave I, Herzum A, et al. Dermatological manifestations of Epstein-Barr virus systemic infection: a case report and literature review. Int J Dermatol 2020;59:1202-9.
10. Drago F, Ciccarese G, Herzum A, et al. Rosacea and alcohol intake. J Am Acad Dermatol 2018;1:25.

How to Cite



1.
Ciccarese G, Bortone R, Meduri AR, Tirone B, Drago F, Foti C, et al. Morbihan disease in an Asian patient: diagnostic and therapeutic challenges. Dermatol Reports [Internet]. 2026 Apr. 28 [cited 2026 Apr. 30];. Available from: https://journals.pagepress.net/dr/article/view/10487